Longitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice

NMR in Biomedicine

Volumn 26, Issue 9, 2013, Pages 1079-1088

  Ye, Qiong ^a   Danzer, Carsten Friedrich ^b   Fuchs, Alexander ^a   Vats, Divya ^a   Wolfrum, Christian ^c   Rudin, Markus ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Institute for Cell Biology   (Switzerland)

^c Laboratory of Translational Nutrition Biology   (Switzerland)

Author keywords

Hepatic lipids (IHCL); Insulin; Magnetic resonance spectroscopy (MRS); Mouse; Obesity

Indexed keywords

ACCURATE QUANTIFICATIONS; HEPATIC LIPIDS (IHCL); MAGNETIC RESONANCE SPECTROSCOPIES (MRS); MOUSE; OBESITY; PLASMA GLUCOSE LEVEL; PLASMA INSULIN LEVELS; POLYUNSATURATED LIPIDS;

DEPOSITION; GLUCOSE; INSULIN; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; PLASMAS;

MAMMALS;

GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALIA; MUS;

HEPATIC LIPIDS (IHCL); INSULIN; MAGNETIC RESONANCE SPECTROSCOPY (MRS); MOUSE; OBESITY;

ANIMALS; BODY WEIGHT; FATTY ACIDS; GLUCOSE; INSULIN; LIPID METABOLISM; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, OBESE;

EID: 84882288465     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2921     Document Type: Article

References (62)

1. Nguyen P, Leray V, Diez M, Serisier S, Le Bloc'h J, Siliart B, Dumon H. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. (Berl). 2008; 92: 272-283.
2. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004; 30: 398-408.
3. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 2008; 14: 72-81.
4. Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of fatty liver. Endocr. Rev. 2008; 29: 939-960.
5. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010; 375: 2267-2277.
6. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clinic. Invest. 2008; 118: 829-838.
7. Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem. 2008; 19: 567-576.
8. Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov. Today 2007. 12: 740-747.
9. Lundbom J, Hakkarainen A, Soderlund S, Westerbacka J, Lundbom N, Taskinen MR. Long-TE (1)H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat. NMR Biomed. 2011. 24: 238-245.
10. Garbow JR, Lin X, Sakata N, Chen Z, Koh D, Schonfeld G. In vivo MRS measurement of liver lipid levels in mice. J. Lipid Res. 2004; 45: 1364-1371.
11. Corbin IR, Furth EE, Pickup S, Siegelman ES, Delikatny EJ. In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy. Bba-Mol. Cell Biol. L. 2009; 1791: 757-763.
12. Bollard ME, Garrod S, Holmes E, Lindon JC, Humpfer E, Spraul M, Nicholson JK. High-resolution (1)H and (1)H-(13)C magic angle spinning NMR spectroscopy of rat liver. Magn. Reson. Med. 2000; 44: 201-207.
13. Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders. Hepatology 2008; 47: 1513-1523.
14. Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J. Lipid Res. 2009; 50 Suppl: S74-79.
15. Zadravec D, Brolinson A, Fisher RM, Carneheim C, Csikasz RI, Bertrand-Michel J, Boren J, Guillou H, Rudling M, Jacobsson A. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB J. 2010; 24: 4366-4377.
16. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol. Behav. 2008; 94: 231-241.
17. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann. Med. 2005; 37: 347-356.
18. Krssak M, Roden M. The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans. Rev. Endocr. Metab. Disord. 2004; 5: 127-134.
19. Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H. Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp. Biol. Med. (Maywood) 2004; 229: 486-493.
20. van Gulik TM, Marsman HA, Heger M, Kloek JJ, Nienhuis SL, van Werven JR, Nederveen AJ, ten Kate FJW, Stoker J. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by 1H-magnetic resonance spectroscopy in a rat model. J. Gastroen. Hepatol. 2011; 26: 356-363.
21. Kotronen A, Seppala-Lindroos A, Vehkavaara S, Bergholm R, Frayn KN, Fielding BA, Yki-Jarvinen H. Liver fat and lipid oxidation in humans. Liver Int. 2009; 29: 1439-1446.
22. Lindstrom P. The physiology of obese-hyperglycemic mice [ob/ob mice]. Scientific World Journal 2007; 7: 666-85.
23. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 2006; 87: 1-16.
24. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo H-1 NMR spectroscopy of rat brain at 1ms echo time. Magn. Reson. Med. 1999; 41: 649-656.
25. Nichols JH HC, Kimberly L, Miller C, Nyberg D, Chan DW. Laboratory and bed side evaluation of portable glucose meters. Am. J. Clin. Pathol. 1995; 103: 244-251.
26. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton nmr-spectra. Magn. Reson. Med. 1993; 30: 672-9.
27. de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL. High magnetic field water and metabolite proton T-1 and T-2 relaxation in rat brain in vivo. Magn. Reson. Med. 2006; 56: 386-394.
28. Ren J, Dimitrov I, Sherry AD, Malloy CR. Composition of adipose tissue and marrow fat in humans by (1)H NMR at 7 Tesla. J. Lipid Res. 2008; 49: 2055-2062.
29. Ye Q, Danzer CF, Fuchs A, Wolfrum C, Rudin M. Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. MAGMA 2012; 25(5): 381-389.
30. Meissburger B, Ukropec J, Roeder E, Beaton N, Geiger M, Teupser D, Civan B, Langhans W, Nawroth PP, Gasperikova D, Rudofsky G, Wolfrum C. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma. EMBO Mol. Med. 2011; 3: 637-651.
31. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am. J. Physiol-Endoc. M. 2007; 293: E1663-E1669.
32. Midtbo LK, Ibrahim MM, Myrmel LS, Aune UL, Alvheim AR, Liland NS, Torstensen BE, Rosenlund G, Liaset B, Brattelid T, Kristiansen K, Madsen L. Intake of farmed atlantic salmon fed soybean oil increases insulin resistance and hepatic lipid accumulation in mice. PLoS One 2013; 8: e53094.
33. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 2008; 118: 829-838.
34. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, Cobelli C, Shulman GI. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A 2006; 103: 18273-18277.
35. Turpin SM, Hoy AJ, Brown RD, Rudaz CG, Honeyman J, Matzaris M, Watt MJ. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011; 54: 146-156.
36. Strobel K, van den Hoff J, Pietzsch J. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo. J. Lipid Res. 2008; 49: 473-480.
37. Machann J, Thamer C, Schnoedt B, Stefan N, Stumvoll M, Haring HU, Claussen CD, Fritsche A, Schick F. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study. Magn. Reson. Mater. Phy. 2005; 18: 128-137.
38. Kaplan ML, Leveille GA. Development of lipogenesis and insulin sensitivity in tissues of the ob/ob mouse. Am. J. Physiol. 1981; 240: E101-107.
39. Menahan LA. Age-related-changes in lipid and carbohydrate-metabolism of the genetically-obese mouse. Metabolism 1983; 32: 172-178.
40. Nishina PM, Lowe S, Wang J, Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 549-553.
41. Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F. Hepatic lipid accumulation in healthy subjects: A comparative study using spectral fat-selective MRI and volume-localized H-1-MR spectroscopy. Magn. Reson. Med. 2006; 55: 913-917.
42. Bredella MA, Ghomi RH, Thomas BJ, Miller KK, Torriani M. Comparison of 3.0T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women. J. Magn. Reson. Imaging 2010; 32: 388-393.
43. Mosconi E, Fontanella M, Sima DM, Van Huffel S, Fiorini S, Sbarbati A, Marzola P. Investigation of adipose tissues in Zucker rats using in vivo and ex vivo magnetic resonance spectroscopy. J. Lipid Res. 2011; 52: 330-226.
44. van Werven JR, Hoogduin JM, Nederveen AJ, van Vliet AA, Wajs E, Vandenberk P, Stroes ES, Stoker J. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. J. Magn. Reson. Imaging 2009; 30: 444-448.
45. Petersen KF, Dufour S, Morino K, Yoo PS, Cline GW, Shulman GI. Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes. Proc Natl Acad Sci U S A. 2012; 109: 8236-40.
46. Peng XG, Ju S, Qin Y, Fang F, Cui X, Liu G, Ni Y, Teng GJ. Quantification of liver fat in mice: comparing dual-echo Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy. J. Lipid Res. 2011 52: 1847-1855.
47. Lundbom J, Hakkarainen A, Fielding B, Soderlund S, Westerbacka J, Taskinen M-R, Lundbom N. Characterizing human adipose tissue lipids by long echo time (1)H-MRS in vivo at 1.5 Tesla: validation by gas chromatography. NMR Biomed. 2010; 23: 466-472.
48. Calderan L, Marzola P, Nicolato E, Fabene PF, Milanese C, Bernardi P, Giordano A, Cinti S, Sbarbati A. In vivo phenotyping of the ob/ob mouse by magnetic resonance imaging and 1H-magnetic resonance spectroscopy. Obesity (Silver Spring) 2006; 14: 405-414.
49. Sharma P, Martin DR, Pineda N, Xu Q, Vos M, Anania F, Hu X. Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction. J. Magn. Reson. Imaging 2009; 29: 629-635.
50. Ye Q, Danzer CF, Fuchs A, Krek W, Mueggler T, Baltes C, Rudin M. Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T. NMR Biomed. 2011; 24: 1295-1301.
51. Matveyenko AV, Butler PC. Relationship between beta-cell mass and diabetes onset. Diabetes Obes. Metab. 2008; 10: 23-31.
52. Edvell A, Lindstrom P. Development of insulin secretory function in young obese hyperglycemic mice (Umea ob/ob). Metabolism 1995; 44: 906-913.
53. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A 1999; 96: 674-679.
54. Warensjo E, Rosell M, Hellenius ML, Vessby B, De Faire U, Riserus U. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis. 2009; 8: 37.
55. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest. 1989; 83: 1168-1173.
56. Summers LK. Adipose tissue metabolism, diabetes and vascular disease--lessons from in vivo studies. Diab. Vasc. Dis. Res. 2006; 3: 12-21.
57. Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Solomon A, Zidovetzki R. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum. 2007; 56: 4164-4173.
58. Hahn P. Cholesterol metabolism in obese mice. Can. J. Biochem. 1980. 58: 1258-1260.
59. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res. Rev. 2006; 5: 144-164.
60. Kotronen A, Seppaelae-Lindroos A, Bergholm R, Yki-Jaervinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia 2008; 51: 130-138.
61. Bozzetto L, Prinster A, Mancini M, Giacco R, De Natale C, Salvatore M, Riccardi G, Rivellese AA, Annuzzi G. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution. Eur. J. Clin. Invest. 2011; 41: 39-44.
62. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461.